Autopsy report · NCT03127449

AST2818 in Advanced Non-Small Cell Lung Cancer With EGFR Mutations

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Indications have been approved for marketing”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 month before it started.
Ran for about 6 years 7 months before it stopped.
116 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Na
Sponsor: Allist Pharmaceuticals, Inc.
Sponsor type: Industry
Conditions: Advanced NSCLC
Interventions: Alflutinib
Participants: 116
Sites: 1
Countries: China

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.